Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
As of April 2026, all new OROS lyophilized product batches are tested through independent ISO-accredited laboratories
First Quarter 2025 Results Lexaria filed its quarterly results for the three-month period ending November 30, 2024
In the peritoneal fluid of patients with endometriosis, the concentration of numerous inflammatory factors, angiogenesis-related factors, and adhesion factors is elevated (3), and the activation of inflammation accelerates the progression of endometriosis (4)
The effect of infections on susceptibility to autoimmune and allergic diseases
The future of injectable care will depend not only on the therapy, but also on the container that supports every dose
US$ 23.36
US$ 21.32
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
US$ 29.33
